5 offerings have no amendment in the last 12 months and may still be open
No amendment in the last 12 months on an offering that may still be open — AI Proteins, Inc. (latest filing Apr 4, 2024) · No amendment in the last 12 months on an offering that may still be open — AI Proteins, Inc. (latest filing Aug 4, 2023) · No amendment in the last 12 months on an offering that may still be open — NextRNA Therapeutics, Inc. (latest filing Jan 27, 2022) · No amendment in the last 12 months on an offering that may still be open — AI Proteins, Inc. (latest filing Jan 21, 2022) · No amendment in the last 12 months on an offering that may still be open — C4 Therapeutics, Inc. (latest filing Jan 11, 2016)
What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.
Sources
- Form D · Apr 4, 2024 ↗ (Apr 4, 2024)
- AI Proteins, Inc. — PartnerFacts page ↗ (Apr 4, 2024)
- Form D · Aug 4, 2023 ↗ (Aug 4, 2023)
- Form D · Jan 27, 2022 ↗ (Jan 27, 2022)
- NextRNA Therapeutics, Inc. — PartnerFacts page ↗ (Jan 27, 2022)
- Form D · Jan 21, 2022 ↗ (Jan 21, 2022)
- Form D · Jan 11, 2016 ↗ (Jan 11, 2016)
- C4 Therapeutics, Inc. — PartnerFacts page ↗ (Jan 11, 2016)